ARCHIVES

FDA Advisory Committee To Consider NDAs On Novantrone, HD MTX

This article is from The Cancer Letter archive.

Vol. 13 No. 46 | November 27, 1987

Download PDF Visit The Full Archive

Related Articles

Anidulafungin Safe And Well-Tolerated In Pediatric Patients With Neutropenia

November 26, 2004

Reader Finds Letter insulting to Ethic Group

February 16, 1996

In Brief: NCI To Go Along With NCAB on Keeping Clinical Education Program Alive; Cal Baldwin Retires

February 28, 1986

Lifestyle Changes Common After Cancer Diagnosis

August 26, 2005

NCI relaxes Core Grants Support For Clinical Trials Research

December 11, 1992

Society Develops Guidelines For Integrative Oncology

August 31, 2007